Ying Qin Zang Selected Research

Neoplasms (Cancer)

4/2010	In vivo disruption of TGF-beta signaling by Smad7 in airway epithelium alleviates allergic asthma but aggravates lung carcinogenesis in mouse.
1/2008	SOCS1 silencing can break high-dose dendritic cell immunotherapy-induced immune tolerance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ying Qin Zang Research Topics

Disease

4	Obesity 01/2012 - 01/2008
4	Inflammation (Inflammations) 12/2010 - 10/2009
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 09/2011 - 05/2009
3	Insulin Resistance 05/2011 - 01/2008
2	Body Weight (Weight, Body) 05/2011 - 01/2009
2	Hyperlipidemias (Hyperlipidemia) 12/2010 - 01/2008
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 08/2010 - 04/2010
2	Neoplasms (Cancer) 04/2010 - 01/2008
2	Cardiovascular Diseases (Cardiovascular Disease) 04/2009 - 01/2009
1	Pancreatic Neoplasms (Pancreatic Cancer) 09/2012
1	Hyperglycemia 09/2011
1	Non-alcoholic Fatty Liver Disease 05/2011
1	Fatty Liver 05/2011
1	Metabolic Diseases (Metabolic Disease) 05/2011
1	Hypoglycemia (Reactive Hypoglycemia) 12/2010
1	Chronic Disease (Chronic Diseases) 08/2010
1	Atrophy 08/2010
1	Autoimmune Diseases (Autoimmune Disease) 08/2010
1	Carcinogenesis 04/2010
1	Lung Neoplasms (Lung Cancer) 04/2010
1	Asthma (Bronchial Asthma) 04/2010
1	Diarrhea 10/2009
1	Multiple Sclerosis 05/2009
1	Disease Progression 05/2009
1	Hepatocellular Carcinoma (Hepatoma) 04/2009
1	Type 2 Diabetes Mellitus (MODY) 01/2009
1	Melanoma (Melanoma, Malignant) 01/2008

Drug/Important Bio-Agent (IBA)

4	CytokinesIBA 05/2011 - 01/2008
3	Glucose (Dextrose)FDA LinkGeneric 12/2010 - 01/2008
3	LipidsIBA 12/2010 - 01/2009
3	Biological ProductsIBA 08/2010 - 04/2009
2	rheinIBA 01/2012 - 05/2011
2	Interleukin-17 (Interleukin 17)IBA 08/2010 - 01/2008
2	BerberineIBA 08/2010 - 10/2009
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2009 - 01/2008
2	PPAR gammaIBA 01/2009 - 01/2008
1	Neoplasm Antigens (Tumor Antigens)IBA 09/2012
1	Liver X ReceptorsIBA 01/2012
1	Uncoupling Protein 1IBA 01/2012
1	Streptozocin (Streptozotocin)FDA Link 09/2011
1	Insulin (Novolin)FDA Link 09/2011
1	AnthraquinonesIBA 05/2011
1	CholesterolIBA 05/2011
1	Pyruvate Dehydrogenase Complex (Dehydrogenase Complex, Pyruvate)IBA 12/2010
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2010
1	Toll-Like Receptor 4IBA 12/2010
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 08/2010
1	Immunoglobulin E (IgE)IBA 04/2010
1	Urethane (Ethyl Carbamate)IBA 04/2010
1	Transforming Growth Factor beta (TGF-beta)IBA 04/2010
1	AntigensIBA 04/2010
1	alpha-galactosylceramideIBA 04/2010
1	AlkaloidsIBA 10/2009
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2009
1	Peptides (Polypeptides)IBA 05/2009
1	Interleukin-4 (Interleukin 4)IBA 05/2009
1	Pharmaceutical PreparationsIBA 05/2009
1	Glatiramer Acetate (Copaxone)FDA Link 05/2009
1	LecithinsIBA 04/2009
1	HDL LipoproteinsIBA 01/2009
1	CarbohydratesIBA 01/2009
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2009
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2009
1	tanshinoneIBA 01/2009
1	DiterpenesIBA 01/2009
1	VaccinesIBA 01/2008
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2008
1	oxidized low density lipoproteinIBA 01/2008

Therapy/Procedure

2	Oral Administration 05/2011 - 10/2009
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 10/2009 - 01/2009
1	Immunomodulation 05/2011